Septerna (SEPN) Cash from Financing Activities (2024 - 2026)
Septerna (SEPN) recorded quarterly Cash from Financing Activities of $333000.0 in Q1 2026, down 67.38% quarter-over-quarter from $1.0 million in Q4 2025, and up 404.55% on a YoY basis from $66000.0 in Q1 2025.
Septerna (SEPN) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Septerna's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $333000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 404.55% year-over-year to $333000.0; the TTM figure through Mar 2026 stood at $2.0 million (down 99.35% YoY), while the FY2025 annual figure was $1.7 million, down 99.55% from the prior year.
- Cash from Financing Activities was $333000.0 for Q1 2026 at Septerna, down from $1.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $304.2 million in Q4 2024 to a low of -$1.3 million in Q3 2024.
- Historically, Cash from Financing Activities has averaged $43.6 million across 3 years, with a median of $333000.0 in 2026.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities sank 99.66% in 2025, then surged 404.55% in 2026.
- A 3-year view of Cash from Financing Activities shows it stood at $304.2 million in 2024, then tumbled by 99.66% to $1.0 million in 2025, then tumbled by 67.38% to $333000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $333000.0 (Q1 2026), $1.0 million (Q4 2025), and $263000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 333,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 333,000.00 |
| Mar 31, 2026 | 333,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 263,000.00 |
| Sep 30, 2025 | 263,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 304.15 Mn |
| Dec 31, 2024 | 304.15 Mn |
| Sep 30, 2024 | -1.32 Mn |
| Sep 30, 2024 | -1.32 Mn |